HIV & Sleep
Why Rest Is So Hard to Find

Start Here Why sleep matters and what usually helps

The short version: Sleep problems are common when you live with HIV. Older regimens containing efavirenz (Sustiva) were notorious for nightmares and insomnia; today most people on modern ART sleep normally, but chronic inflammation, aging, mental health, and stress still disrupt sleep for many. Good sleep is not a luxury — it is part of your immune health. What follows is what to look for, what medications to talk to your provider about, and habits that actually work.

How Common Is Sleep Disruption in PLHIV?

Sleep problems are among the most frequently reported but least discussed symptoms among people living with HIV. Research consistently shows that 50 to 70 percent of PLHIV experience clinically significant sleep disturbances — rates two to three times higher than the general population. These aren't minor complaints about occasional bad nights. They are persistent, disruptive, and directly connected to quality of life, immune function, and mental health.

The problem spans all stages of HIV disease. People who are newly diagnosed, people on effective treatment with undetectable viral loads, and long-term survivors all report elevated rates of insomnia, non-restorative sleep, and excessive daytime sleepiness. Being on antiretroviral therapy helps many aspects of HIV management profoundly — but it does not automatically resolve sleep disruption, and in some cases it contributes to it.

Despite how common sleep problems are in this population, they are frequently undertreated. Patients often don't bring it up because they assume poor sleep is just part of living with HIV. Providers often don't screen for it because the appointment is already full with other concerns. The result is a significant unmet need that affects millions of people living with HIV globally.

If you are not sleeping well, it is worth naming that to your provider — specifically, with detail about what's happening. Not "I'm tired," but: do you have trouble falling asleep, staying asleep, or both? Do you wake unrefreshed? Do you feel sleepy during the day even after a full night? The answers point toward different causes and different interventions.

The Inflammation Connection

Even in people living with HIV who are virally suppressed on effective treatment, chronic low-level immune activation persists. HIV triggers an inflammatory response that the immune system never fully turns off — even when the virus itself is undetectable. This ongoing inflammation has effects throughout the body, and sleep is one of the most significant targets.

Inflammatory cytokines — chemical messengers produced by immune cells — directly regulate sleep architecture. In normal immune function, cytokines like IL-1 and TNF-alpha rise during sleep and contribute to slow-wave (deep) sleep. In chronic inflammatory states, this regulation becomes dysregulated. The result is fragmented sleep, reduced time in restorative deep sleep stages, and increased nighttime waking.

This is why treating the underlying HIV infection — achieving and maintaining viral suppression — is the most important long-term intervention for sleep quality in PLHIV. It doesn't resolve all sleep problems, but reducing the viral burden reduces the inflammatory burden, which creates the foundation for better sleep.

Research also suggests that the duration of HIV infection matters. Long-term survivors who spent years with uncontrolled viral replication before effective treatment was available may carry a higher inflammatory baseline than people who started treatment early. This is not a reason for despair — it's a reason to be proactive about sleep management as part of overall aging-with-HIV care.

How Antiretroviral Medications Affect Sleep

Antiretroviral therapy is non-negotiable — it is the foundation of HIV care and the most important tool for long-term health. But some ARVs have known effects on sleep, and understanding which medications affect sleep and how can help you and your provider make informed decisions about regimen timing or composition.

Sleep Apnea & HIV — An Underrecognized Connection

Obstructive sleep apnea (OSA) — a condition in which breathing repeatedly stops and starts during sleep — is more common in PLHIV than in the general population, and it is significantly underdiagnosed in this group. Research suggests PLHIV have rates of sleep apnea that are two to four times higher than comparable HIV-negative individuals.

Several HIV-specific factors contribute to this elevated risk. Chronic inflammation affects the upper airway muscles and tissue. Lipodystrophy — fat redistribution associated with both HIV and certain older ART regimens — can increase fat deposits in the neck and throat, narrowing the airway. Nasal congestion from immune activation or certain medications can force mouth breathing during sleep. And the sleep fragmentation caused by other HIV-related sleep disorders can overlap with and mask apnea symptoms.

Sleep apnea is diagnosable and treatable. A sleep study — which can now often be done at home with a portable monitoring device — is the standard diagnostic tool. CPAP therapy (continuous positive airway pressure) is the most effective treatment for moderate to severe OSA and has been shown to improve not just sleep quality but also immune function, cardiovascular health, and quality of life in PLHIV.

If you are experiencing excessive daytime sleepiness that doesn't improve with better sleep hygiene, or if you have any of the signs above, raise sleep apnea specifically with your provider. Asking for a referral to a sleep specialist is appropriate and often necessary — primary care and HIV providers don't always screen for OSA proactively.

Fatigue vs. Sleep Disruption — They Are Not the Same Thing

This distinction matters enormously — both for how you describe your experience to your provider and for what interventions are likely to help. Fatigue and sleep disruption are related but separate problems, and treating one as if it were the other often leads to frustration on both sides of the exam table.

Many PLHIV experience both simultaneously — and the two reinforce each other. Poor sleep worsens fatigue. Fatigue-driven inactivity worsens sleep quality. Breaking this cycle requires identifying which problem is primary and addressing both in parallel.

When you talk to your provider, try to be specific: "I fall asleep fine but wake at 3am and can't get back to sleep" is different from "I sleep eight hours and wake feeling like I didn't sleep at all" which is different from "I can't stay awake during the day no matter how much I sleep." Each description points toward a different cause.

Mental Health & Sleep — The Bidirectional Relationship

Depression and anxiety are significantly more prevalent among PLHIV than in the general population — and both have profound effects on sleep. Depression is associated with early morning awakening, non-restorative sleep, and hypersomnia. Anxiety and post-traumatic stress are associated with difficulty falling asleep, hyperarousal, and nightmares. When you carry a diagnosis that comes with stigma, uncertainty, and for many people a history of loss — the psychological burden on sleep is real and clinically significant.

The relationship runs in both directions. Poor sleep worsens depression and anxiety. Depression and anxiety worsen sleep. This bidirectional loop is one of the most important — and most treatable — drivers of sleep disruption in PLHIV.

Addressing the mental health component is often the most effective route to better sleep — not just treating the sleep problem in isolation. If depression or anxiety is contributing to your sleep disruption, treating those conditions is likely to improve sleep more effectively than sleep aids alone. Talk therapy, particularly Cognitive Behavioral Therapy for Insomnia (CBT-I), has the strongest evidence base for treating insomnia in people with co-occurring mental health conditions.

What Actually Helps — Evidence-Based Interventions

Sleep problems in PLHIV are real, multifactorial, and treatable. The following interventions have evidence behind them — ranging from first-line behavioral approaches to clinical treatments that require provider involvement. Start with the behavioral approaches, which cost nothing and have no side effects. Add clinical support as needed.

• Cognitive Behavioral Therapy for Insomnia (CBT-I) — the gold standard for treating chronic insomnia. More effective than sleep medications for long-term outcomes. Addresses the thoughts, behaviors, and sleep environment patterns that perpetuate insomnia. Available through sleep specialists, therapists trained in CBT-I, and digital programs. Ask your provider for a referral or look for the Sleepio app or similar evidence-based digital CBT-I tools.
• Consistent sleep and wake times — going to bed and waking at the same time every day, including weekends, is one of the most powerful regulators of the body's internal clock. Irregular sleep timing is a significant driver of insomnia and daytime sleepiness.
• ART timing review — if your current regimen includes medications known to affect sleep, ask your provider whether a morning dose or a regimen switch is appropriate. Do not change timing on your own — some medications have food requirements or drug interaction considerations that affect when they can be taken.
• Sleep apnea evaluation and treatment — if you have symptoms consistent with OSA, getting diagnosed and starting CPAP can dramatically improve sleep quality, energy levels, and cardiovascular health. This is a clinical intervention that requires a referral, but the impact is significant.
• Exercise — particularly in the morning or afternoon — regular aerobic exercise improves sleep quality in PLHIV and reduces inflammatory markers. Timing matters: vigorous exercise too close to bedtime can be activating for some people. Morning sunlight exposure combined with exercise is particularly effective for circadian regulation.
• Light management — bright light in the morning helps anchor the circadian clock. Reducing blue light (phones, screens) in the hour before bed reduces melatonin suppression. Low-dose melatonin (0.5–3mg) taken 60–90 minutes before the desired sleep time can help with sleep onset, particularly for circadian disruption. Talk to your provider about whether melatonin is appropriate given your other medications.
• Mental health treatment — if depression, anxiety, or PTSD is contributing to sleep disruption, treating those conditions is often the most direct path to better sleep. Therapy, medication, or both may be appropriate depending on your situation and history.
• Sleep medication — thoughtfully, not reflexively — some PLHIV benefit from sleep aids, but long-term benzodiazepine use is associated with dependence, cognitive effects, and respiratory depression that can worsen sleep apnea. Non-benzodiazepine sleep aids and melatonin receptor agonists may be appropriate for some people. This is a conversation for your provider — not a first-line self-treatment.

Florida — Finding Sleep and Mental Health Support